Gabrielle Strobel Interviews Vincent Marchesi
Alzforum scientific advisor Vincent Marchesi is currently director of the Boyer Center of Molecular Medicine at Yale University School of Medicine.
ALL NEWS
6397 RESULTS
Sort By:
- Most Recent
- Most Commented
Ancient Defense Mechanism Causes Collateral Damage to Neurons
In the 24 June PNAS Early Edition, researchers report that a biologically ancient defense mechanism for ridding the central nervous system (CNS) of invading pathogens also damages neurons...
U.S. Study Questions the Value of CJD Test
Soon after the World Health Organization bestowed its approval on the protein 14-3-3 as an important diagnostic marker for sporadic Creutzfeldt-Jakob disease (sCJD), reports began to come in that its sensitivity and specificity might not be all that was advertised...
Nicotine and β Amyloid—Smoking Guns?
Papers in press in the Journal of Biological Chemistry and PNAS explore the relationship between Alzheimer's disease (AD) and nicotine...
FDA Approves L-dopa Cocktail for Parkinson’s
The U.S. Food and Drug Administration has given approval for the drug Stalevo—a cocktail of levodopa (L-dopa), carbidopa, and entacapone—to be marketed in the United States for the treatment of Parkinson's disease...
Plugging Up the Blood-Brain Barrier
The blood-brain barrier (BBB) is cropping up with increasing frequency in discussions of Alzheimer's disease therapy. It is an ever-present concern for researchers hoping to introduce therapies...
Nonprofit Foundation Strikes Deal with Stem Cell Pioneer
The not-for-profit Amyotrophic Lateral Sclerosis-Therapy Development Foundation (ALS-TDF), based in Newton, Massachusetts, has entered into a collaboration with University of Chicago stem cell researcher Kimonobu Sugaya...
Spotlight on the DJ: Crystal Structure Solved of Parkinson's Protein
Two in-press papers in the Journal of Biological Chemistry reveal the crystal structure of DJ-1, a protein of unknown function that was recently implicated in the etiology of familial Parkinson's disease...
Small Molecules Turn Stem Cells into Neurons, Targeting GSK3β
In last week's PNAS online, researchers reported that murine embryonic stem cells exposed to pyrrolpyrimidines differentiate into neurons. This result raises hope that the fate of stem cells in vivo may one day be controlled by the use of small molecules...
Nature/Aventis Horizon Symposium: Understanding the RNAissance
News Pointer: RNAi Horizon Symposium Highlights Nature/Aventis Horizon Symposium: Understanding the RNAissance
News Pointer: RNAi Horizon Symposium Highlights
Enjoy an online summary of a <a href="http://www.nature.com/horizon/rna/index.html">Nature/Aventis Horizon Symposium</a> held last month in Maine...
Is SOD's Contribution to Lou Gehrig’s Disease Unfolding?
Mutations in the enzyme Cu/Zn superoxide dismutase (SOD) have been linked to about 20 percent of familial cases of amyotrophic lateral sclerosis (ALS), but there is no explanation yet for how the mutations contribute to ALS pathology...
Naproxen/Rofecoxib Trial Results Published
Both selective (COX-2 inhibitor, rofecoxib) and nonselective (COX-1/COX-2 inhibitor, naproxen) nonsteroidal antiinflammatory drugs (NSAIDs) fail to slow the cognitive decline associated with Alzheimer's disease (AD)...
Adult Neurogenesis in the "Black Substance"
Dopaminergic neurons in the mouse substantia nigra are replenished throughout the life of the animal, according to a report in the June 2 early online edition of PNAS...
Antibodies Found That Specifically Target Infectious Prions
Antibodies can be raised that specifically target misfolded prion proteins, leaving native proteins free to carry on their normal functions. This is the conclusion of a paper which appeared in yesterday's Nature Medicine online...
Current Filters
- Date Range : All x